Want to see HK:1508 full AI Analyst Report?
China Reinsurance (Group) Corp. Class H (1508) AI Stock Analysis
Top Page
China Reinsurance (Group) Corp. Class H
(HKEX:1508)
The score is driven primarily by solid financial performance with strong cash-flow support and a 2025 rebound, plus very attractive valuation (low P/E and high dividend yield). Offsetting these positives are elevated balance-sheet risk from the sharp 2025 debt increase and mixed technicals (improving short-term trend but still below the 200-day average).
China Reinsurance (Group) Corp. Class H (1508) vs. iShares MSCI Hong Kong ETF (EWH)
- Market Cap
- HKD 50.55B
- Dividend Yield
- 6.68%
- Average Volume (3M)
- 11.37M
- Price to Earnings (P/E)
- 4.2
- Beta (1Y)
- 1.15
- Revenue Growth
- 10.91%
- EPS Growth
- 0.92%
- Country
- Hong Kong
- Employees
- 41,861
- Sector
- Financial
- Sector Strength
- 68
- Industry
- Insurance - Reinsurance
China Reinsurance (Group) Corp. Class H Business Overview & Revenue Model
Company Description
China Reinsurance (Group) Corporation, along with its affiliated companies, functions as a leading reinsurance enterprise operating within the People's Republic of China and internationally. Its diverse business activities are structured into key seg...
China Reinsurance (Group) Corp. Class H Financial Statement Overview
Summary
Financials show solid profitability and strong cash generation, highlighted by a sharp 2025 rebound (revenue +16.4% YoY; free cash flow +87.8% YoY). However, results have been cyclical (including a 2022 loss and 2024 revenue decline), and the sharp increase in total debt in 2025 meaningfully raises balance-sheet risk despite a sizable equity base.
Income Statement
66PositiveBalance Sheet
62PositiveCash Flow
74Positive| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 123.01B | 113.12B | 85.54B | 94.96B | 88.27B | 163.95B |
| Gross Profit | 78.09B | 113.00B | 85.54B | 94.96B | 2.21B | 163.95B |
| EBITDA | 15.14B | 14.90B | 17.04B | 3.28B | 1.58B | 10.38B |
| Net Income | 10.56B | 9.52B | 10.56B | 5.65B | -324.64M | 5.95B |
Balance Sheet | ||||||
| Total Assets | 531.00B | 527.99B | 508.35B | 459.73B | 424.73B | 499.80B |
| Cash, Cash Equivalents and Short-Term Investments | 19.36B | 16.63B | 158.31B | 10.30B | 10.97B | 18.74B |
| Total Debt | 75.79B | 13.80B | 13.97B | 15.43B | 17.96B | 27.46B |
| Total Liabilities | 408.46B | 408.62B | 395.68B | 357.55B | 327.24B | 397.71B |
| Stockholders Equity | 112.54B | 109.69B | 103.26B | 93.25B | 86.02B | 92.71B |
Cash Flow | ||||||
| Free Cash Flow | 23.22B | 28.16B | 9.91B | 15.86B | 11.31B | 9.12B |
| Operating Cash Flow | 23.64B | 28.56B | 10.35B | 16.29B | 11.71B | 9.56B |
| Investing Cash Flow | -24.49B | -1.88B | -18.56B | -14.83B | -6.80B | -15.57B |
| Financing Cash Flow | 2.67B | -16.58B | 4.62B | 999.20M | -12.20B | 14.01B |
China Reinsurance (Group) Corp. Class H Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:1508, the sentiment is Negative. The current price of 1.19 is below the 20-day moving average (MA) of 1.20, below the 50-day MA of 1.23, and below the 200-day MA of 1.31, indicating a bearish trend. The MACD of -0.02 indicates Positive momentum. The RSI at 47.51 is Neutral, neither overbought nor oversold. The STOCH value of 42.72 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:1508.
China Reinsurance (Group) Corp. Class H Peers Comparison
Overall Rating
HK:096685Outperform- HK:150872Outperform
HK:182870Outperform
HK:696366Neutral
HK:606059Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| HK:0966 | 85Outperform | HKD 60.95B | 1.89 | 33.37% | 7.25% | 18.51% | 293.61% |
| HK:1508 | 72Outperform | HKD 50.55B | 4.17 | 9.50% | 6.68% | 10.91% | 0.92% |
| HK:1828 | 70Outperform | HKD 41.69B | 4.89 | 6.07% | ― | 24.23% | ― |
| Sector * | 68Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% |
| HK:6963 | 66Neutral | HKD 40.14B | 4.49 | 13.21% | 6.26% | 7.54% | 39.14% |
| HK:6060 | 59Neutral | HKD 15.14B | 6.46 | 7.57% | ― | 15.60% | 49.14% |
* Financial Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| HK:1508 | China Reinsurance (Group) Corp. Class H | 1.19 | -0.29 | -19.54% | |
| HK:6060 | ZhongAn Online P & C Insurance | 8.98 | -7.91 | -46.83% | |
| HK:0966 | China Taiping Insurance Holdings Co | 16.96 | 0.37 | 2.20% | |
| HK:6963 | Sunshine Insurance Group Co. Ltd. | 3.49 | 0.06 | 1.81% | |
| HK:1828 | FWD Group Holdings Limited | 32.58 | -7.46 | -18.63% |
China Reinsurance (Group) Corp. Class H Corporate Events
China Reinsurance Posts Strong Solvency and Steady Earnings for Q3 2026
China Reinsurance (Group) Corporation has reported solid solvency positions across the Group for the third quarter of 2026, with core and aggregated solvency adequacy ratios well above regulatory minimums at both the holding company and its main subs...
China Reinsurance Discloses Unaudited 2026 Nine-Month Financials for Key Subsidiaries
China Reinsurance (Group) Corporation announced unaudited financial data for the nine months ended 30 September 2026 for its subsidiaries China Re P&C and China Re Life, prepared under PRC Accounting Standards. The disclosure is part of ongoing t...
China Reinsurance Secures CSRC Approval for Targeted Domestic Share Issuance
China Reinsurance (Group) Corporation has received approval from the China Securities Regulatory Commission to register its planned issuance of domestic shares to a specific investor. The approval, which is valid for 12 months, allows the company to...
China Reinsurance Wins Shareholder Backing for New Share Issuance Mandates
China Reinsurance (Group) Corporation obtained strong shareholder support at its third extraordinary general meeting of 2026, with all special resolutions passed by large majorities. Key approvals included a general mandate for the board to issue sha...
China Reinsurance Sets EGM to Approve New Share Issuance and Subscription Deal
China Reinsurance (Group) Corporation has called its third extraordinary general meeting of 2026 for 24 September in Beijing to seek shareholder approval for a series of capital-related resolutions. The agenda includes granting the board a general ma...
China Reinsurance Seeks Board Mandate for Targeted Share Issuance
China Reinsurance (Group) Corporation has proposed granting its board a general mandate to issue new domestic and H shares, enabling the company to allot, issue or deal with up to 10% of each share class in issue, excluding treasury shares. The move...
China Reinsurance secures approval for new director as board awaits full regulatory sign-off
China Reinsurance (Group) Corporation has received regulatory approval from the National Financial Regulatory Administration for the qualification of Lyu Zhi as a non-executive director, vice chairman of the audit committee and member of the related-...
China Reinsurance Clarifies Board Structure and Committee Roles
China Reinsurance (Group) Corporation has confirmed the composition of its nine-member board, specifying executive, non-executive and independent non-executive directors along with the roles of chairman and vice chairlady. The clarified governance st...
China Reinsurance Posts Higher Interim Profit on Strong Investment Income
China Reinsurance (Group) Corporation reported unaudited interim results for the six months ended 30 June 2026, showing total income of RMB63.4 billion, up from RMB61.0 billion a year earlier, driven by higher insurance revenue and notably stronger i...
China Reinsurance Subsidiaries to Disclose 2026 Interim Solvency Reports After Bond Issues
China Reinsurance (Group) Corporation announced that its key subsidiaries, China Property and Casualty Reinsurance Company Ltd. and China Life Reinsurance Company Ltd., have previously completed multiple tranches of capital supplementary bond issuanc...
China Reinsurance Schedules Board Meeting to Approve 2026 Interim Results
China Reinsurance (Group) Corporation has scheduled a meeting of its board of directors for Friday, 28 August 2026 in order to review and approve the interim results for the six months ended 30 June 2026. The meeting will also address any other busin...
China Reinsurance Announces Board Changes After Regulator Clears New Director
China Reinsurance (Group) Corporation has received regulatory approval from the National Financial Regulatory Administration for the qualification of Mr. He Xingda as a non-executive director. His appointment also covers roles as a member of the audi...
China Reinsurance (Group) Corp Details Board and Committee Structure
China Reinsurance (Group) Corporation, a Hong Kong-listed joint stock limited liability company based in the People’s Republic of China, operates in the reinsurance and broader insurance services industry. Its board is structured with executive...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Aug 06, 2026